Hot Features
Premium
Trade like a pro: Leverage real-time discussions and market-moving ideas to outperform.
Period:
Draw Mode:
| Volume | 0 |
|
|||||
| News | - | ||||||
| Day High | Low High |
||||||
| Day Low | |||||||
| Share Name | Share Symbol | Market | Stock Type |
|---|---|---|---|
| Nymox Pharmaceutical Corp | NYMX | NASDAQ | Common Stock |
| Price Change | Price Change % | Share Price | Last Trade
|
|
|---|---|---|---|---|
| 0.00 | 0.00% | 0.20 | 19:00:00 |
| Open Price | Low Price | High Price | Close Price | Previous Close |
|---|---|---|---|---|
| 0.20 | 0.20 |
| Trades | Shares Traded | Average Volume | 52 Week Range |
|---|---|---|---|
| 0 | 0 | - | 0.1688 - 0.495 |
| Last Trade | Type | Quantity | Price | Currency |
|---|---|---|---|---|
| - | 0 | US$ 0.20 | USD |
Nymox Pharmaceutical Corp Financials
| Market Cap | Shares in Issue | Float | Revenue | Profit/Loss | EPS | PE Ratio |
|---|---|---|---|---|---|---|
| 18.1M | 90.52M | - | 0 | -6.58M | -0.07 | - |
| Short Interest | Dividends Per Share | Dividend Yield | Ex-Div Date | Insider B/S | Insider % Owned |
|---|---|---|---|---|---|
| - | - | - | - |
Nymox Pharmaceutical News
| Date | Time | Source | News Article |
|---|---|---|---|
| 3/28/2024 | 12:03 | Edgar (US Regulatory) | Form 6-K - Report of foreign issuer [Rules 13a-16 and.. |
| 11/06/2023 | 08:59 | Edgar (US Regulatory) | Form 6-K - Report of foreign issuer [Rules 13a-16 and.. |
| 9/08/2023 | 09:13 | Edgar (US Regulatory) | Form 25-NSE - Notification filed by national security.. |
| 7/25/2023 | 15:04 | Edgar (US Regulatory) | Form 6-K - Report of foreign issuer [Rules 13a-16 and.. |
| 7/25/2023 | 09:33 | GlobeNewswire Inc. | Nymox Reports Successful New NYMOZARFEX (TM) Long-Term.. |
| 7/18/2023 | 09:45 | GlobeNewswire Inc. | Nymox Reports on U.S. Patent Issuances |
| 7/13/2023 | 09:16 | GlobeNewswire Inc. | Nymox Update |
| 7/12/2023 | 08:30 | GlobeNewswire Inc. | Nymox Announces Appointment Of Patrick Doody as Vice.. |
| 7/07/2023 | 16:02 | GlobeNewswire Inc. | NYMOX Update |
| 7/05/2023 | 17:11 | GlobeNewswire Inc. | Nymox Delisting from NASDAQ |
| 6/29/2023 | 16:15 | Edgar (US Regulatory) | Form 6-K - Report of foreign issuer [Rules 13a-16 and.. |
| 5/10/2023 | 09:00 | GlobeNewswire Inc. | Nymox Provides Current Update |
|
|
{{bbMessage.M_Alias}} {{bbMessage.MSG_Date}} {{bbMessage.HowLongAgo}} {{bbMessage.MSG_ID}} {{bbMessage.MSG_Subject}} |
Loading Messages....
Historical NYMX Price Data
| Period † | Open | High | Low | VWAP | Avg. Daily Vol | Change | % |
|---|---|---|---|---|---|---|---|
| 1 Week | 0.00 | 0.00 | 0.00 | 0.00 | 0 | 0.00 | 0.00% |
| 1 Month | 0.00 | 0.00 | 0.00 | 0.00 | 0 | 0.00 | 0.00% |
| 3 Months | 0.00 | 0.00 | 0.00 | 0.00 | 0 | 0.00 | 0.00% |
| 6 Months | 0.00 | 0.00 | 0.00 | 0.00 | 0 | 0.00 | 0.00% |
| 1 Year | 0.4018 | 0.495 | 0.1688 | 0.2770886 | 159,446 | -0.2018 | -50.22% |
| 3 Years | 2.02 | 2.27 | 0.1688 | 1.02 | 223,963 | -1.82 | -90.10% |
| 5 Years | 1.83 | 4.90 | 0.1688 | 1.69 | 193,867 | -1.63 | -89.07% |
Nymox Pharmaceutical Description
| Nymox Pharmaceutical Corp is a biopharmaceutical company focused on developing its drug candidate, NX-1207, for the treatment of BPH and the treatment of low-grade localized prostate cancer. |
